PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...

 
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
CONNECT AND COLLABORATE THROUGH BIOBANKING:
POWERING INNOVATION AND DISCOVERY

PROGRAM
MAY 10–14 (WESTERN HEMISPHERE)
MAY 11–15 (EASTERN HEMISPHERE)
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
Connect Globally to Leading
Professionals in Biobanking                                                JOIN ISBER
ISBER’s vision is to be the leading network in the global
                                                                             TODAY!
biobanking and biorepository community.
ISBER advances the expertise and quality of biorepositories
and biobanking science worldwide.                                          WWW.ISBER.ORG

BENEFITS OF MEMBERSHIP INCLUDE:

   Free access to the ISBER Best Practices for Repositories and ISBER
   Biobank Assessment Tool (BAT)
   Opportunity to connect with a global group of professionals in biobanking
   through the ISBER Members-only Forum
   Access to Biopreservation and Biobanking (BIO), ISBER’s official journal
   Reduced registration rates to ISBER meetings
   Stay informed with the latest biorepository news through the online ISBER News

      NEW ISBER MEMBERS RECEIVE
15% OFF THEIR FIRST-YEAR OF MEMBERSHIP!
     READY TO JOIN? VISIT ISBER.ORG!
                                Head Office: Suite 301, 750 West Pender Street, Vancouver, BC, Canada, V6C 2T7
  leading since 1999              T: 1-604-484-5693 • F: 1-604-874-4378 E: info@isber.org W: www.isber.org
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

                              To be the leading network in the global
      Vision                  biobanking and biorepository community.

                              ISBER advances the expertise and quality
      Mission                 of biorepositories and biobanking science
                              worldwide.

            International Society for Biological and Environmental Repositories
    750 Pender Street, Suite 301, Vancouver, BC V6C 2T7 Canada | T 604.484.5693 | F 604.874.4378   3
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

    ISBER SPONSORS
    GOLD SPONSORS:

    SILVER SPONSORS:

    BRONZE SPONSORS:

4
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

TABLE OF CONTENTS
   Message from the ISBER President and Scientific Program Committee..................................6
   ISBER Board of Directors and Committee Chairs............................................................... 10
   ISBER Committee, Working Group and SIG Listing............................................................11
   ISBER 2021 Award Recipients........................................................................................ 13
   General Conference Information.................................................................................... 14
   Description of Virtual Session Types................................................................................ 15
   Conference-at-a-Glance................................................................................................ 16
   Conference Program.................................................................................................... 18
   Speaker and Workshop Presentation Summaries.............................................................. 31
   Round Table Discussion Summaries................................................................................46
   Abstract Poster Listing..................................................................................................49
   Exhibitor Listing...........................................................................................................53

                                                                                                                                    5
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

    MESSAGE FROM THE ISBER PRESIDENT AND SCIENTIFIC
    PROGRAM COMMITTEE
    Dear Colleagues and friends,                                       ISBER 2021 will host a wide range of experts working in the
                                                                       different steps of the same food chain, academia, hospitals,
    Welcome to the International Society for Biological and
                                                                       biological & life sciences, clinical diagnostics, and pharma
    Environmental Repositories (ISBER) 2021 Annual Meeting.
                                                                       biotech. Those experts will share their experience and dis-
    While we do not have a host city this year, we have the
                                                                       cuss how closer collaboration can lead to more successful
    opportunity instead to present our meeting virtually to the
                                                                       future research and development and address the needs to
    world! This year will be ISBER’s first completely virtual meet-
                                                                       facilitate such collaboration.
    ing and we are anxious and excited to share our colleagues’
    research!
                                                                         PRE CONFERENCE WORKSHOP
    Our theme this year is, “Connect and Collaborate through
    Biobanking: Powering Innovation and Discovery,” and this           The annual meeting begins this year with the Biobanking
    year has certainly been a year of connecting and collaborat-       101 workshop held virtually from April 28th-29th. Topics of
    ing for everyone. While we have always connected and col-          discussion were the Qualification of Biorepository Science
    laborated with fellow biobankers, this past year it has been       (QBRS), emergency planning for biobanking, and basic
    more important than ever to bring together experts in their        business planning for biobanking.
    fields to share their knowledge and experience with ISBER
    members around the globe.                                            PROGRAM HIGHLIGHTS

    Biobanks are among the most important enablers of med-             World leaders have been invited by our Scientific Program
    ical research and pharmaceutical development. Be it aca-           Committee to present in their areas of expertise. The four
    demic research in hospitals, diagnostic test development in        day program includes round table discussions, a Keynote
    biotechnological institutes or R&D of vaccines or drugs in         address, eleven symposia sessions, four contributed paper
    pharmaceutical companies, they all depend on the crucial           sessions, six educational workshops, networking opportu-
    data encapsulated in biological samples. And all of those          nities, and opportunities to network with ISBER members
    scientists are dedicated to one common vision: improving           and learn from our corporate sponsors during sponsor
    quality of life and health care.                                   showcase presentations, corporate workshops, and within
                                                                       the exhibit hall.
    Availability of high quality biological samples, however, can-
    not be taken for granted and reaching that common vision           With this year being the first year that ISBER has hosted a
    oftentimes does not come easy. To overcome existing ob-            virtual meeting, we have the unique opportunity to have our
    stacles, we need one thing above all: more collaboration.          speaker’s presentations available for on-demand viewing af-
    Collaboration requires the realization that all of us are in the   ter the conclusion of the conference. Additionally, we have
    same boat and are pulling in the same direction. It requires       asked our ISBER members to submit biobank profile videos
    the realization that together we are stronger.                     highlighting their unique biobank operations.
    As devastating as the COVID-19 pandemic has been for the           On Monday and Wednesday afternoons, there are a num-
    world it has at least shown us the truth in those assumptions.     ber of educational workshops to choose from. These have
    Never have diagnostic tests, or vaccines, been successfully        been submitted by the biobanking community to share
    developed with such speed. Keeping up and promoting                knowledge and expertise with the ISBER audience.
    the spirit of collaboration is what the ISBER 2021 confer-         We were thrilled to have over 80 abstract submissions for
    ence is about.                                                     our conference this year! Four contributed paper sessions

6
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

will be held on Tuesday and Thursday afternoons where se-        Symposium 2B, “The Nurture of Nature”, provides a plat-
lected topics of research will be presented. Additionally, a     form to discuss the vastly diverse environmental collections
virtual poster session will be available to attendees with a     that serve as an invaluable resource of knowledge and tell
wide range of biorepository topics of interest. Samples from     stories from environmental biobanks and the value they pro-
the moon, anyone?                                                vide for the biobanking community.

PLENARY SYMPOSIA                                                 Wednesday, May 12
                                                                 Wednesday morning begins with our first round table dis-
Monday, May 10
                                                                 cussions of the annual meeting. Topics of discussion in dif-
On the first day of the meeting, our ISBER President,            ferent virtual meeting rooms range from biobanking in LMIC
Associate Professor Daniel Catchpoole, will provide a wel-       in the post COVID-19 era, auditing tools, integrating new
come to our attendees, followed by a, “Top of the Morning”       collections, NMR tools, cell and gene therapy, and compli-
address from Scientific Program Co-Chairs Amanda Moors           ance experience in the pharma industry.
and Benjamin Otto. Next, we will have our Keynote address
                                                                 Immediately following the round table discussions, we will
from Dr. Jim Vaught. Dr. Vaught is one of ISBER’s founding
                                                                 welcome our attendees with a morning brief followed by
members and served two terms as president. He has spent
                                                                 two concurrent symposia. Symposium 3A, is ISBER’s first
over 20 years dedicated to biospecimen sciences and re-
                                                                 Symposium on the field of food standards and biobanking,
ceived the ISBER Founder’s Award in 2018.
                                                                 “Biobanking in the Food industry: Where Standards are Easy
Two concurrent symposia will take place on Monday                to Digest.” In Symposium 3B, “Biobanking Sustainability
morning, all with equally intriguing topics of discussion.       in the Light of the COVID-19 Pandemic”, speakers will share
Symposium 1A, “Lessons learned from the COVID-19                 their perspectives and lessons-learned from before, during
Pandemic”, will highlight the collaboration and sharing of       and on emerging from the pandemic, on the value and
expertise of samples and of data across academia, industry       practicality of sustained biobanking.
and governmental institutions demonstrating how it is vital
                                                                 Wednesday afternoon will host three concurrent workshops.
for medical research, for successful development of diag-
nostics tests and treatments but as well for sustainability of   Thursday, May 13
research projects. In Symposium 1B, “The Microbiome -
                                                                 On Thursday morning, we will open with a networking
Making a Macro-Impact”, researchers will discuss microbi-
                                                                 event, followed by a welcome and meeting brief. Two con-
ome collections, and possibilities and limitations associated
                                                                 current symposia will follow. Symposium 4A, “Making
with microbiome research.
                                                                 Biospecimens an Informatics Challenge: Navigating Our
Monday afternoon, three concurrent educational work-             Way to Innovation,” takes a look at samples through a lens
shops will take place.                                           where the main value of the sample is the information en-
                                                                 capsulated within and where biospecimens are integral to
Tuesday, May 11
                                                                 an informatics driven discovery process, and engaging with
On Tuesday morning, we will welcome our members with             the informatics industries as active partners. In Symposium
a networking event and morning brief, then two concurrent        4B, “Data Sharing Network for Sharing Evidence-Based
symposia follow. Symposium 2A, “Research and Treatment           Solutions,” information will be shared highlighting how bio-
for All – Connecting Research and Implementation to              banks play a crucial role in providing tools to examine data
Underserved and Vulnerable Communities,” highlights              from those receiving treatment, those being vaccinated,
the importance of including underserved and vulnerable           along with reviewing the current and long treatment out-
communities in biobanking and a roadmap to address               comes associated with the novel coronavirus disease.
the missing communities and populations. Concurrently,

                                                                                                                                7
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

    CONTRIBUTED PAPERS SESSIONS, CORPORATE                           ACKNOWLEDGEMENTS
    WORKSHOPS, AND POSTER PRESENTATIONS
                                                                   Our annual meeting would not have had such amazing
    Contributed Papers Sessions                                    success without our invited speakers, guests, and work-
    There are four contributed paper sessions to be held on        shop presenters; thank you very much for your contribution
    Tuesday and Thursday afternoons. Selected abstracts were       to the biobanking community and for making ISBER 2021
    submitted, reviewed, and selected for presentation.            a success! Members of the ISBER 2021 Scientific Program
                                                                   Committee, as well as the Organizing Advisory Committee
    Corporate Workshops                                            (OAC), contributed a tremendous amount of time and price-
                                                                   less energy over the past year to present a comprehensive
    Be sure to attend the corporate workshops taking place on
                                                                   annual meeting to ISBER members.
    Tuesday, May 11. Hamilton Storage will be presenting on
    transitioning to an automated biobank, including advantag-     We greatly appreciate the support received from our ven-
    es, best practices, and a case study. Agilent Technologies     dors and sponsors whose participation also made our meet-
    will be presenting on biobank sample quality control with      ing successful. Please visit the virtual exhibit hall and attend
    automated electrophoresis. Lastly, GA International will be    the corporate workshops.
    presenting on breakthrough labeling technologies for bio-
                                                                   Thank you to the ISBER Head Office staff for their support
    banks and high-throughput labs.
                                                                   and guidance throughout this year under the guidance of
                                                                   Ana Torres. We are very thankful to Samantha Wale for her
    POSTER SESSIONS
                                                                   patience and guidance as we navigated through planning
    This year, 63 posters will be presented in a virtual poster    our first virtual conference.
    hall. Poster presentations will also be considered for ISBER   ISBER 2021 is not intended to be a once a year event. To en-
    Poster Award which recognized excellence in poster pre-        sure future successful meetings, consider joining an ISBER
    sentations at the annual meeting. The goal of the ISBER        committee, or complete the online survey at the end of the
    poster award is to encourage ISBER members and all at-         meeting. We hope that this gathering of colleagues will the
    tendees of the annual meeting who are new investigators        start, or continue, a great future of even stronger collabora-
    in biobanking to ask important, original questions about       tion and networking, and this is our invitation to join us on
    biobanking and biospecimen science, to design sound,           this journey.
    controlled experiments with a clear rationale, and to pres-
    ent the results clearly in a poster format.                    Thank you for your participation and enjoy the meeting.
                                                                   With kindest regards,

                                                                   Daniel Catchpoole, PhD, FFSc
                                                                   ISBER President, 2021-2022

                                                                   Amanda Moors
                                                                   Co-Chair of the ISBER 2021 Scientific Program Advisory Committee

                                                                   Benjamin Otto
                                                                   Co-Chair of the ISBER 2021 Scientific Program Advisory Committee

8
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
ULTRA LOW TEMPERATURE FREEZERS:
KEY CONSIDERATIONS FOR COVID-19 VACCINES
Many cold chain issues occur in the “last mile/kilometre”
of vaccine distribution, with samples lost due to improperly
                                                                                                                                                         ULTRA LOW TEMPERATURE FREEZERS:
handled freezers. ISBER, the International Society for                                                                                                   KEY CONSIDERATIONS FOR COVID-19 VACCINES
                                                                                                                                                         Many cold chain issues occur in the “last

Biological and Environmental Repositories, offers our shared
                                                                                                                                                                                                                          For more information on the
                                                                                                                                                         mile/kilometre” of vaccine distribution, with                    Best Practices referenced here visit
                                                                                                                                                         samples lost due to improperly handled                           (or scan QR Code):
                                                                                                                                                                                                                          isber.org/page/BPR
                                                                                                                                                         freezers. ISBER, the International Society for                   Training Resources available at:
                                                                                                                                                         Biological and Environmental Repositories,                       isber.org/page/webinars-on-demand

expertise in cold chain management to educate new users                                                                                                  offers our shared expertise in cold chain
                                                                                                                                                         management to educate new users of ultra-
                                                                                                                                                         low temperature (ULT) -70C freezers as part of                   STAFF TRAINING
                                                                                                                                                         SARS-COV-2 vaccine distribution programs.                        IS CRITICAL
of ultra-low temperature (ULT) -70°C freezers as part of the                                                                                                   This document is intended to
                                                                                                                                                            provide guidance for managing the
                                                                                                                                                                                                                          o Provide all vaccination staff
                                                                                                                                                                                                                            with proper training in cold
                                                                                                                                                                                                                            chain supply, freezer operations
                                                                                                                                                                                                                            and frozen sample handling.
                                                                                                                                                           deployment of frozen COVID vaccines.

SARS-COV-2 vaccine distribution programs.                                                                                                                    ULT FREEZER SELECTION MUST                                           ISBER Best Practices C.3. Mechanical Freezers
                                                                                                                                                                                                                                  & B.5. Backup Power
                                                                                                                                                             MEET LOCAL REQUIREMENTS
                                                                                                                                                             o   Choose freezers with the widest temperature range to accommodate vaccine
                                                                                                                                                                 candidates and choose the smallest freezer required.
                                                                                                                                                             o   Confirm the power configuration available in your lab prior to purchase, especially in

o STAFF TRAINING IS CRITICAL
                                                                                                                                                                 areas with low-grade power supply.
                                                                                                                                                             o   Have a dedicated backup power system in place in case of power outage.
                                                                                                                                                             o   Install an independent internal thermometer sensor to log/alert against temperature
                                                                                                                                                                 fluctuations. Ensure internet or Wi-Fi access and send alerts to multiple staff.

o ULT FREEZER SELECTION MUST                                                                                                                                 ULT FREEZER
                                                                                                                                                             INSTALLATION
                                                                                                                                                                                                                           ULT FREEZER
                                                                                                                                                                                                                           OPERATION AND

  MEET LOCAL REQUIREMENTS
                                                                                                                                                             REQUIRES A SPECIFIC                                           MAINTENANCE MUST
                                                                                                                                                             STORAGE AREA                                                  BE COORDINATED
                                                     ULTRA-LOW TEMPERATURE FREEZERS                                                                            ISBER Best Practices B. Facilities                            ISBER Best Practices C.12 Equipment Maintenance

                                                                                                                                                                                                                           o Access to vaccines needs a strict procedure
                                                     KEY CONSIDERATIONS FOR COVID-19 VACCINES:
                                                                                      o Each freezer requires an independent circuit.
                                                                                        Ensure outlets are on an emergency circuit                                                                                           for how staff will manage door openings.

o ULT FREEZER INSTALLATION
                                                                                                                                                                                                                             Aim for few and short door openings to avoid
                                                                                                SUPPLEMENT                                                         with built-in redundancy.
                                                                                                                                                               o Ensure room where freezer will be housed
                                                                                                                                                                                                                             freezer temperature fluctuations. Allow the
                                                                                                                                                                   can handle additional heat load. ULT units will           freezer to return to set temperature.
                                                CONTRIBUTORS:                                                                                                                                                              o Avoid an empty unit. If you do not have
                                                                                                                                                                   increase humidity and temperature.
                                                                                                                                                                                                                             product to fill the unit, consider adding
                                                                                                                                                               o ULT     freezers    need to pull air in

  REQUIRES A SPECIFIC
                                                • Dan R. Catchpoole, President, ISBER.; Biospecimen Research Services, CCRU, Kids Research, Sydney Children’s Hospital Network, Westmead,
                                                                                                                                                                   and exhaust without restriction.                          empty aluminum racks to fill it.
                                                  Australia. Daniel.catchpoole@health.nsw.gov.au
                                                • Piper Mullins, President Elect, ISBER; Smithsonian Institution, Washington, DC, USA. MullinsP@si.edu             Check clearance requirements                            o Regularly clean the
                                                • Jim Vaught, Editor-in-Chief, Biopreservation & Biobanking, USA. jvaught44@gmail.com                              outlined by each manufacturer                             condenser and gaskets
                                                • Cheryl Michels, Freezerworks, USA. cheryl@dwdev.com                                                              before purchase.                                          to prevent ice formation,
                                                •   Monique Albert, Secretary, ISBER; Ontario Tumour Bank, Ontario Institute for Cancer Research, Canada. Monique.Albert@oicr.on.ca                                          especially around doors.

  STORAGE AREA                                                                                                                                                                                                             o Ensure ULT freezers are
                                                •   Alison Parry Jones, Director-at-Large for Europe, the Middle East and Africa, ISBER; Wales Cancer Bank, Wales. Parry-JonesA@cardiff.ac.uk
                                                •   Daniel Simeon Dubach, Chair, Standards Committee ISBER; Medservice, Switzerland. daniel.simeon-dubach@medservice.ch                                                      calibrated for accuracy of
                                                •   Molly Ferrara, Hamilton Storage Technologies Inc, USA. mferrara@hamilton-storage.com                                                                                     temperature display.
                                                •   Ian Pope, IC Biomedical, USA. ipope@icbiomedical.com
                                                •   Tim Root, Stirling Ultracold, USA. troot@stirlingultracold.com
                                                •   Mark Sawicki, Cryoport Systems, USA. msawicki@cryoport.com                                               ULT FREEZER
                                                •   Pasquale De Blasio, Integrated Systems Engineering, Italy. pasquale.deblasio@isenet.it
                                                                                                                                                             EMERGENCY PLANNING

o ULT FREEZER OPERATION
                                                •   Andy Pazahanick, Select Gases, USA. apazahanick@selectgases.com
                                                •   Tracy Fogle, Diversified Laboratory Repair, Inc. USA. tfogle@dlrepair.com
                                                •   Buzz Bies, MVE Biological Solutions, USA. Buzz.bies@MVEbio.com                                                     ISBER Best Practices B.8 Emergency Preparedness

                                                                                                                                                             o Draft an emergency plan in case
                                                Many cold chain issues occur in the “last mile/kilometre” of vaccine distribution, with samples of   lostfreezer
                                                                                                                                                           due to failure, power outage,

  AND MAINTENANCE MUST BE
                                                                                                                                                                   improperly
                                                                                                                                                     natural
                                                handled freezers. ISBER, the International Society for Biological and Environmental Repositories, offers       disaster,
                                                                                                                                                         our shared      and other
                                                                                                                                                                     expertise
                                                in cold chain management to educate new users of ultralow temperature (ULT) -70°C freezers as part   common      hazards.
                                                                                                                                                         of COVID-19  vaccine
                                                distribution programs.                                                                          o Have a written procedure
                                                                                                                                                                 for transferring specimens to

  COORDINATED
                                                                                                                                                                 alternative storage (e.g. dry ice).
                                                    For more information on the Best Practices referenced here visit
                                                    (or scan QR Code): isber.org/page/BPR
                                                                                                                                                                                                                                 www.isber.org

                                                PURPOSE

o ULT FREEZER EMERGENCY
                                                This document is intended to provide guidance managing the deployment of frozen COVID-19 vaccines. It is not designed to be
                                                a comprehensive series of instructions on cold chain management. Rather this is designed to be a guide to the considerations
                                                that need to be addressed by managers wishing to set up a robust system for the SARS-CoV-2 vaccine deployment.

  PLANNING

  For more information on the
  Best Practices referenced here visit
  (or scan QR Code):
  isber.org/page/BPR
  Training Resources available at:
  isber.org/page/webinars-on-demand
                                                                                                                                                           www.isber.org
PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
PROGRAM

     ISBER BOARD OF DIRECTORS AND COMMITTEE CHAIRS
      ISBER BOARD MEMBERS

     Daniel Catchpoole, PhD, FFSc             Debra Leiolani Garcia, MPA              Piper Mullins, MS
     PRESIDENT 2020-2021                      PAST-PRESIDENT 2020-2021                PRESIDENT-ELECT 2020-2021
     Tumor Bank, The Children’s Hospital at   California, United States               Smithsonian Institution
     Westmead                                                                         Washington DC, United States
     New South Wales, Australia

     Jane Carpenter, MAppSci                  Monique Albert, MSc, PMP
     TREASURER                                SECRETARY
     NSW Health Pathology                     Ontario Institute for Cancer Research
     New South Wales, Australia               Ontario, Canada

      ISBER BOARD MEMBERS: DIRECTORS-AT-LARGE

     Diane McGarvey, QBRScm                   Xun Xu, PhD                             Alison Parry-Jones, PhD, MA, MRSC
     DIRECTOR-AT-LARGE - Americas             DIRECTOR-AT-LARGE - China               DIRECTOR-AT-LARGE - Europe, Middle
     CHTN Eastern Division                    China National GeneBank                 East, and Africa
     Pennsylvania, United States              Guangdong, China                        Wales Cancer Bank - Cardiff University
                                                                                      South Glamorgan, United Kingdom

     Koh Furuta, MD, PhD                      EXECUTIVE DIRECTOR
     DIRECTOR-AT-LARGE - Indo-Pacific Rim     Ana Torres, BA (Hon), MPub, CAE
     Director, Urayasu Warakuen Clinic        British Columbia, Canada
     Urayasu, Japan

      COMMITTEE CHAIRS

     Catherine Seiler, PhD                    Kristina E. Hill, MPH, MT(ASCP)         Shonali Paul, BE, MBA
     COMMUNICATIONS COMMITTEE CHAIR EDUCATION AND TRAINING                            MEMBER RELATIONS COMMITTEE CHAIR
     H3 Biomedicine                 COMMITTEE CHAIR                                   CloudLIMS.com
     Massachusetts, United States             Independent Consultant                  Madhya Pradesh, India
                                              Florida, United States

     Zisis Kozlakidis, PhD, MBA, FLS          Marianna Bledsoe, MA                    Daniel Simeon-Dubach, MD, MHA
     ORGANIZING COMMITTEE CHAIR               SCIENCE POLICY COMMITTEE CHAIR          STANDARDS COMMITTEE CHAIR
     IARC/WHO                                 Independent Consultant                  medservice
     Auvergne-Rhône-Alpes, France             Colorado, United States                 Walchwil, Switzerland

10
PROGRAM

ISBER COMMITTEE, WORKING GROUP, AND SPECIAL INTEREST
GROUP LISTING
EDUCATION & TRAINING    ORGANIZING ADVISORY            STANDARDS ADVISORY            2021 PROGRAM
ADVISORY COMMITTEE      COMMITTEE                      COMMITTEE                     COMMITTEE
Chair: Kristina Hill    Chair: Zisis Kozlakidis        Chair: Daniel Simeon-Dubach   Co-Chair: Amanda Moors
Members:                Vice Chair: Judita Kinkorova   Vice-Chair: Clare Allocca     Co-Chair: Benajmin Otto
Ahmed Abdelhafiz        Vice Chair: Billy Schleif      Monique Albert                Monique Albert
Marta Castelhano        Members:                       Cory Arant                    Catherine Alix-Panabieres
Diane McGarvey          Monique Albert                 Sergey Anisimov               Nahla Afifi
Kathy Sexton            Daniel Catchpoole              Karolin Bergenstrahle         Clare Allocca
Tamsin Tarling          Jane Carpenter                 Yehudit Cohen                 Jane Carpenter
                        Jason Chen                     Annemieke De Wilde            Daniel Catchpoole
MEMBER RELATIONS        Debra Garcia                   Bonginkosi Duma               Debra Garcia
                        Marianne Henderson             Helena Ellis                  Lotte Glück
ADVISORY COMMITTEE      Diane McGarvey                 Koh Furuta                    Oliver Karch
Chair: Shonali Paul     Amanda Moors                   Samantha Higgins              Cari Lichtman
Members:                Piper Mullins                  Shannon McCall                Diane McGarvey
Judith Giri             Benjamin Otto                  Timothy Sharp                 Kirstin Goldring
Marianne Henderson      Alison Parry-Jones             Karine Sargsyan               Elaine Gunter
Piper Mullins           Andy Pazahanick                Brent Schacter                Marianne Henderson
Benjamin Otto           Ayat Salman                    Weiping Shao                  Cheryl Michels
Yunice Shao             Brent Schacter                 Rajeev Singh                  Piper Mullins
Rosy Singh              Daniel Simeon-Dubach           Emma Snapes                   Morten Oien
Xuexun Zhou                                            Carmen Swanepoel              Suenne Orth
Avashoni Zwane          COMMUNICATIONS                 Dana Valley                   Shonali Paul
Judita Kinkorova                                       Ran Wang                      Andy Pazahanick
                        ADVISORY COMMITTEE             Peter Watson                  Pascal Puchois
                        Chair: Catherine Seiler                                      Daniel Simeon-Dubach
NOMINATING COMMITTEE                                                                 YanRu Su
                        Vice-Chair: Ayat Salman
                        Robert Hewitt                  SCIENCE POLICY                Tatsuaki Tsuruyama
Chair: Debra Garcia
                        Emily Hubbard                  ADVISORY COMMITTEE            Hanh Vu
Members:
                        Lise Matzke                                                  Heidi Wagner
Buzz Bies                                              Chair: Marianna Bledsoe
                        Jim Vaught                                                   Andy Zaayenga
Daniel Catchpoole                                      Vice-Chair: Helen Morrin
Rongxing Gan            Carol Weil
                        Andy Zaayenga                  Members:                      ISBER WORKING GROUPS
Allison Hubel                                          Kelsey Dillehay McPhillip
William Mathieson                                      Aaron Goldenberg
Diane McGarvey                                                                       •   Biospecimen Science
                        FINANCE COMMITTEE              Catherine Kennedy             •   Enviro-Bio
Shonali Paul                                           Rita Lawlor
Alison Parry-Jones      Chair: Jane Carpenter                                        •   Informatics
                                                       Tohru Masui                   •   International Repository
Andy Pazahanick         Members:                       Michaela Mayrhofer
Brent Schacter          Monique Albert                                                   Locator
                                                       Elizabeth Mayne               •   Pharma
Kathi Shea              Daniel Catchpoole              Alison Parry-Jones
                        Debra Garcia                                                 •   Rare Diseases
                                                       Brent Schacter                •   Regulatory and Ethics
GOVERNANCE              Jesus Monico                   Lana Skirboll
                        Piper Mullins                  Caoimhe Vallely-Gilroy
COMMITTEE               Rajeev Singh                                                 ISBER SPECIAL INTEREST
                                                       Carol Weil
Chair: Monique Albert                                                                GROUPS
Members:
Monique Albert                                                                       •   Automated Repositories
Koh Furuta                                                                           •   Next Generation Living
Debra Garcia                                                                             Biobank
Alison Parry-Jones                                                                   •   Pediatric
Billy Schlief                                                                        •   Donors
Stella Somiari
Heidi Wagner

                                                                                                                    11
PROGRAM

ISBER 2021 AWARD RECIPIENTS
  ISBER OUTSTANDING ACHIEVEMENT IN BIOBANKING
The ISBER Award for Outstanding Achievement in Biobanking is designed to recognize individuals who have made out-
standing contributions to the field of biobanking. The award can be given for a single outstanding achievement or a lifetime
body of outstanding work in the field.

                                                ANDREW BROOKS, USA

  ISBER PIONEER’S AWARD
The ISBER Pioneer’s Award, sponsored by MVE Biological Solutions, recognizes individuals who provided outstanding lead-
ership to the founding, support, and incorporation of ISBER as an international biobanking society, as well as long standing
contributors who have played critical roles in developing and executing ISBER’s vision and mission.

                                              FAY BETSOU, LUXEMBOURG

  ISBER DISTINGUISHED LEADERSHIP AND SERVICE AWARD
The ISBER Distinguished Leadership and Service Award is designed to honor ISBER members who have demonstrated
exceptional leadership to further the mission and goals of the society and/or significant, long-standing contributions to
the society.

                                                 NICOLE SIEFFERT, USA

  ISBER SPECIAL SERVICES AWARDS
The ISBER Special Service Awards recognize individuals who have made exceptional contributions towards the goals of the
Society through the performance of a special service or act on behalf of the organization.

                                                 CLARE ALLOCCA, USA
                                         KAROLIN BERGENSTRÅHLE, SWEDEN
                                         ANUSHA HETTIARATCHI, AUSTRALIA
                                                   BILLY SCHLEIF, USA
                                               HEIDI WAGNER, CANADA
                                                BIRENDRA YADAV, INDIA

                                                                                                                               13
PROGRAM

     GENERAL CONFERENCE INFORMATION
     EDT = American Eastern Daylight Time                                  BIOBANKING 101 WORKSHOP
                                                                           PRE-REGISTRATION REQUIRED
       VIRTUAL PLATFORM                                                  The Biobanking 101 workshop is taking place over two days:
     All delegates have been provided with a personal link to
     join the meeting platform via email. If you do not have this        Wednesday, April 28 2:30pm – 5:00pm
     link, you may go to the following link and enter your email         SUCCESS IS THE RESULT OF PREPARATION: EMERGENCY
     address to be re-sent your login link:                              PLANNING FOR BIOBANKS
                                                                         QUALIFICATION IN BIOREPOSITORY SCIENCE
     https://isber.econference.io/public/4irSk29

       CONFERENCE SUPPORT:                                               Thursday, April 29 10:00am – 12:00pm
                                                                         BASIC BUSINESS PLANNING FOR BIOBANKING
     Thursday, May 6               11:00pm – 1:00am
     Friday, May 7                 11:00am – 2:00pm
     Monday, May 10                9:00am – 5:00pm                                       TO REGISTER, CLICK HERE
     Tuesday, May 11               9:00am – 5:00pm
     Wednesday, May 12             9:00am – 5:00pm                         NETWORKING EVENTS/LOUNGE
     Thursday, May 13              9:00am – 5:00pm
                                                                         Various networking activities have been planned throughout
       EXHIBIT HOURS:                                                    the meeting. Furthermore, all delegates are able to look up
                                                                         and connect with other delegates throughout the meeting
     Exhibit booths will be available throughout the entirety of         using the “attendee listing”. Specific networking activities are
     the meeting. Specific visiting hours are:                           scheduled as follows:
     Monday, May 10                10:45am – 11:15am                     Tuesday, May 11:
     Tuesday, May 11               11:00am – 11:30am                     • 8:45 – 9:30am: Drop-in networking in lounge
     Wednesday, May 12             11:00am – 11:30am,                    • 7:15pm – 8:00pm: Drop-in networking in lounge
                                   9:30pm – 10:30pm                      Wednesday, May 12:
     Thursday, May 13              11:00am – 11:30am                     • 8:45 – 9:30am: Round Table Discussions
                                                                         • 7:15pm – 8:00pm: Round Table Discussions
       REGISTRATION RATES (PRICES IN USD)
                                                                         Thursday, May 13:
     All delegates are encouraged to register for the meeting a          • 8:45 – 9:30am: Drop-in networking in lounge
     minimum of one week in advance of the start date to ensure          • 2:45pm – 3:45pm: Round Table Discussions
     that you receive your login details in time for the first day       • 7:15pm – 8:00pm: Drop-in networking in lounge
     of the meeting. It may take up to two business days to pro-         Friday, May 14:
     cess new registrations and provide login details after May          • 7:15pm – 8:00pm: Drop-in networking in lounge
     5, 2021.
                                                                           CERTIFICATES OF ATTENDANCE
                                Regular      “On-Site” Rate
                                Rate         *Registration after May 5
                                                                         All attendees will receive a certificate of attendance electron-
     ISBER Member               $370         $460                        ically upon completing the post-conference delegate evalua-
                                                                         tion. This will be distributed via email following the meeting.
     Non-ISBER Member           $460         $575
     Technician/Student                                                    POSTER PRESENTATION INFORMATION:
                                $230         $230
     Member
                                                                         Posters are available in the “poster hall” throughout the
     Registration for the annual meeting includes access to all live     entirety of the meeting. Poster presenters will be available
     and recorded content. Sessions recordings will continue to          within their poster area for videoconferencing with dele-
     be available for 60 days following the end of the meeting.          gates during the two poster sessions:
                                                                         Poster Session 1: Tuesday, May 11, 4:00pm – 5:00pm
                                                                         Poster Session 2: Thursday, May 13, 4:00pm – 5:00pm
14
PROGRAM

DESCRIPTION OF VIRTUAL SESSION TYPES
  LIVE SESSIONS                                                    NETWORKING ACTIVITIES
The majority of sessions at the ISBER 2021 Annual Meeting        The ISBER Annual Meeting will feature a networking lounge
will be live sessions. This means that you will attend them at   that will be available throughout the entirety of the meeting
the time they are scheduled to take place in the program.        for drop in networking. Specific networking sessions will
                                                                 also take place in this lounge.
Within 24 hours of a live session, the recording of the ses-
sion will become available for on-demand viewing. The re-        You are invited to hang out in the lounge during break times
cording will be available throughout the remainder of the        to take advantage of this opportunity to connect with dele-
meeting and for 60 days following the event.                     gates from around the globe.

  ON-DEMAND SESSIONS                                               ROUND TABLE DISCUSSIONS
Some sessions at the ISBER 2021 Annual Meeting are pre-re-       There are three round table discussion sessions scheduled
corded and available for viewing at your leisure. These ses-     at the meeting. These are informal discussions with a facilita-
sions will become available for viewing at the start of the      tor that allow delegates with similar interests to discuss hot
conference and will be available throughout the entirety of      topics, challenges, and/or opportunities in biobanking.
the conference and for 60 days following the event.              These are a great networking opportunity and all delegates
                                                                 are encouraged to attend.
To access “on-demand” sessions, you will navigate to the
“on-demand” section in the virtual platform menu.
                                                                   POSTER ABSTRACT PRESENTATIONS
  WORKSHOPS                                                      The abstract posters will be available for viewing in the
                                                                 “poster hall” throughout the entirety of the meeting. During
Educational workshops will be live, interactive sessions.
                                                                 the specific poster presentation sessions in the program,
This means that you will attend them at the time they are
                                                                 the poster presenters will be available within their poster
scheduled to take place in the program. Given the interac-
                                                                 rooms for videoconferencing with delegates.
tive nature of workshops, only summary recordings will be
available for on-demand viewing following the session.
                                                                   VISIT WITH EXHIBITORS
Workshops will take place via Zoom Meeting. If you are un-
able to install the Zoom application on your device you can      Exhibit booths will be available throughout the entirety of
join using the web version of Zoom.                              the meeting in the “exhibit hall”. Exhibit staff will be avail-
The Biobanking 101 workshop recording is also available for      able at their booths during the scheduled “visit with exhib-
purchase if you missed the session. Please visit www.isber.      itors” sessions for videoconferencing with delegates. You
org to purchase this session.                                    may also schedule meetings with exhibitor staff.

PLEASE JOIN US AT THE ISBER
ANNUAL GENERAL MEETING!

MAY 19, 2021                        3:00 PM PDT / 6:00PM EDT / NEXT DAY 12:00AM CEST / NEXT DAY 6:00AM CST (CHINA) /
                                    NEXT DAY 7:00AM JST (JAPAN) / NEXT DAY 8:00AM AEST (AUSTRALIA)

The Annual General Meeting of the International Society for Biological and Environmental Repositories will be held May
19, 2021. The meeting will be an electronic meeting. All members are invited to join the ISBER Annual General Meeting!
                                                                                                                                   15

FOR MORE INFORMATION, VISIT: WWW.ISBER.ORG/PAGE/2021AGM OR EMAIL INFO@ISBER.ORG
All times listed in Americas Eastern Daylight Time   PROGRAM

     MEETING-AT-A-GLANCE
     All times listed in Americas Eastern Daylight Time

       WEDNESDAY, APRIL 28
     2:30pm – 5:00pm           BIOBANKING 101: PART 1 *Pre-registration is required

       THURSDAY, APRIL 29
     10:00am – 12:00pm         BIOBANKING 101: PART 2 *Pre-registration is required

       THURSDAY, MAY 6
     All Day                   Virtual Platform Available for Browsing
     11:00pm – 1:00am          Technical Support Open
     (next day)

       FRIDAY, MAY 7
     All Day                   Virtual Platform Available for Browsing
     11:00am – 2:00pm          Technical Support Open

       MONDAY, MAY 10
     8:30am – 5:00pm           Technical Support Open
     9:00am                    ALL ON-DEMAND SESSIONS BECOME AVAILABLE
     9:00am – 5:00pm           Exhibit Hall Open
     9:30am – 10:45am          WELCOME AND KEYNOTE
     10:45am – 11:15am         Visit with Exhibitors
     11:15am – 1:45pm          SYMPOSIUM 1A/1B
     2:30pm – 5:00pm           EDUCATIONAL WORKSHOPS 1/2/3

       TUESDAY, MAY 11
     8:30am – 5:00pm           Technical Support Open
     8:30am – 5:00pm           Exhibit Hall Open
     8:45am – 9:30am           Coffee and Networking
     9:30am – 9:45am           TOP OF THE MORNING
     10:00am – 12:45pm         SYMPOSIUM 2A/2B
     11:00am – 11:30am         Visit with Exhibitors
     1:30pm – 2:30pm           CONTRIBUTED PAPER SESSIONS 1/2

16
PROGRAM             All times listed in Americas Eastern Daylight Time

 TUESDAY, MAY 11
3:00pm – 4:00pm     CORPORATE WORKSHOPS 1/2/3
4:00pm – 5:00pm     POSTER PRESENTATIONS
7:15pm – 8:00pm     Drop-in Networking

 WEDNESDAY, MAY 12
8:30am – 5:00pm     Technical Support Open
8:30am – 5:00pm     Exhibit Hall Open
8:45am – 9:30am     ROUND TABLE DISCUSSIONS
9:30am – 9:45am     TOP OF THE MORNING
10:00am – 12:45pm   SYMPOSIUM 3A/3B
11:00am – 11:30am   Visit with Exhibitors
1:30pm – 4:00pm     EDUCATIONAL WORKSHOPS 4/5/6
7:15pm – 8:00pm     ROUND TABLE DISCUSSIONS

 THURSDAY, MAY 13
8:30am – 5:00pm     Technical Support Open
8:30am – 5:00pm     Exhibit Hall Open
8:45am – 9:30am     Coffee and Networking
9:30am – 9:45am     TOP OF THE MORNING
10:00am – 12:30pm   SYMPOSIUM 4A/4B
11:00am – 11:30am   Visit with Exhibitors
1:15pm – 2:15pm     CONTRIBUTED PAPER SESSIONS 3/4
2:45pm – 3:45pm     ROUND TABLE DISCUSSIONS
4:00pm – 5:00pm     POSTER PRESENTATIONS
5:00pm – 5:15pm     CLOSING REMARKS
7:15pm – 8:00pm     Drop-in Networking

 FRIDAY, MAY 14
7:15pm – 8:00pm     Drop-in Networking

                                                                         17
All times listed in Americas Eastern Daylight Time   PROGRAM

     MEETING PROGRAM
      WEDNESDAY, APRIL 28
                         BIOBANKING 101: PART 1 *Pre-registration is required
                         Chair: Marianne Henderson

                                                  QUALIFICATION IN BIOREPOSITORY SCIENCE
                         2:30pm – 3:00pm
                                                  Brent Schacter, CancerCare Manitoba, Canada
     2:30pm – 5:00pm
                                                  SUCCESS IS THE RESULT OF PREPARATION: EMERGENCY PLANNING FOR
                         3:00pm – 5:00pm          BIOBANKING
                                                  Helen Morrin, University of Otago Christchurch, New Zealand, Rebecca Pugh, National Institute of
                                                  Standards and Technology, USA

      THURSDAY, APRIL 29
                         BIOBANKING 101: PART 2 *Pre-registration is required
                         Chair: Debra Garcia
     10:00am – 12:00pm   BASIC BUSINESS PLANNING FOR BIOBANKING
                         Marianne Henderson, National Cancer Institute, USA, Daniel Simeon-Dubach, medservice, Switzerland, Kirstin Goldring,
                         AstraZeneca, UK

      THURSDAY, MAY 6
     All Day             Virtual Platform Available for Browsing
     11:00pm – 1:00am    Technical Support Open
     (next day)

      FRIDAY, MAY 7
     All Day             Virtual Platform Available for Browsing
     11:00am – 2:00pm    Technical Support Open

      MONDAY, MAY 10
     8:30am – 5:00pm     Technical Support Open
     9:00am – 5:00pm     Exhibit Hall Open
                         ON-DEMAND SESSIONS BECOME AVAILABLE:
                         RISING STARS: THE NEXT GENERATION OF BIOBANKERS
                         Chairs: Hanh Vu, Debra Garcia, Zisis Kozlakidis
                         This session aims to promote new stars in biobanking, including young biobanks, newbie biobankers, and
                         new achievements of biobanking. Show the world your first stone and your baby steps, let them know how
                         tough you are! This session creates a dancing zone for any early-stage aspects of biobanking. It is also a chance
                         to show your needs, and we are all together to help.
     9:00am
                         OKADAI BIOBANK: BIOBANK-AS-A-SERVICE IN A UNIVERSITY HOSPITAL IN JAPAN
                         Mizuki Morita, Okayama University, Japan

                         THE CURRENT STATUS OF BIOBANKING IN VIETNAM
                         Tiến Anh Ngô, Vinmec Healthcare System, Vietnam

                         AN INDIAN EXPERIENCE WITH THE PROGRESS OF NATIONAL BIOBANK
18                       Birendra Kumar Yadav, National Liver Disease Biobank, India
PROGRAM             All times listed in Americas Eastern Daylight Time

MONDAY, MAY 10
                 EFFECT OF ASCORBIC ACID ON METABOLIC STATUS, LIPID PEROXIDATION, ANTIOXIDANT ACTIVITY
                 AND QUALITY OF FROZEN INDIAN RED JUNGLE FOWL (GALLUS GALLUS MURGHI) SEMEN
                 Bushra Allah Rakha, Pir Mehr Ali Shah Arid Agriculture University Rawalpindi, Pakistan

                 BIOBANK CANCER HOSPITAL: 14 YEARS IN TRANSLATION CANCER RESEARCH
                 Márcia Marques Silveira, Barretos Cancer Hospital, Brazil

                 WHAT YOU NEED TO KNOW TO COOPERATE WITH PHARMA AND THE DIAGNOSTICS INDUSTRY
                 Chairs: Pascal Puchois, Michael Roehrl
                 Since human biospecimens are a critical resource to translate research from bench to bedside, collaboration
                 between industry and biobanks is of paramount importance. This important collaboration is often sub-opti-
                 mal, as the parties each have their own unique priorities, requirements, and regulatory constraints. During
                 this session, we will explain the main drivers behind industry demand for biospecimens and the perspective
                 of academic biobanks, highlight some obstacles to collaboration, and explore potential solutions to optimize
                 co-operation.
                 This session has been organized by the ISBER Pharma Working Group.
                 WHAT ARE THE MAIN BIOSPECIMEN SOURCES USED BY PHARMA-IVD INDUSTRY?
                 Pascal Puchois, Trans-Hit Biomarkers, a Brooks Life Sciences Company, Canada

                 COLLABORATION BETWEEN ACADEMIC BIOBANKS AND BIOTECH INDUSTRY: PITFALLS AND
                 LESSONS LEARNED
                 Daniel Simeon-Dubach, medservice, Switzerland

                 MATERIAL TRANSFER AGREEMENTS: HOW TO ALIGN INDUSTRY’S AND ACADEMIA’S INTERESTS
                 Donna Wren, Faber Daeufer & Itrato P.C., USA

                 GETTING AN ASSAY TO MARKET: AN INTRODUCTION TO MEDICAL DEVICE REGISTRATION
                 Kerry Powers, Ventana, USA
9:00am           THE SYNERGISTIC PARTNERSHIP BETWEEN PHARMA AND ACADEMIC PATHOLOGY FOR
                 COMPANION DIAGNOSTICS
                 Michael Roehrl, Memorial Sloan Kettering Cancer Center, USA

                 AN INCREASED NEED FOR BUILDING PROSPECTIVE FIT FOR PURPOSE BIOSPECIMEN COLLECTIONS:
                 IMPACT ON R&D PROGRAMS
                 Suresh Selvaraj, Genentech, USA

                 PRE-ANALYTIC VARIABLES IN A HIGH QUALITY BIOBANK WITH A FOCUS ON RECRUITING SUBJECTS
                 WHO ARE UNDER REPRESENTED IN BIOSPECIMEN COLLECTION
                 Chris Andry, Boston Medical Center, USA

                 LIQUID BIOPSY IN CANCER PATIENTS
                 Chair: Catherine Alix-Panabières
                 Biobanking, pre-analytical and analytical steps are important steps to detect circulating biomarkers in blood
                 samples from patients with a solid cancer. Liquid biopsy-based assays will be introduced in clinical routine in
                 the near future. However, we need to initiate more intervention clinical trials, combine different circulating
                 biomarkers depending on the cancer type, and define guidelines and SOP for their analyses.
                 INTRODUCTION
                 Catherine Alix-Panabières, University Medical Center Goettingen, Germany

                 BIOBANKING OF LIQUID BIOPSY IN LUNG CANCER: OPPORTUNITIES AND ISSUES
                 Paul Hofman, Université Côte d’Azur, France

                 EXTRACELLULAR VESIBLES: FROM CELL-CELL COMMUNICATION TO BIOMARKERS DISCOVERY
                 Bruno Costa -Silva, Champalimaud Foundation, Portugal

                 UTILITY OF CIRCULATING TUMOR DNA AS A RESPONSE AND FOLLOW-UP MARKER IN CANCER
                 THERAPY
                 Ellen Heitzer, Medical University of Graz, Austria

                                                                                                                                   19
All times listed in Americas Eastern Daylight Time    PROGRAM

      MONDAY, MAY 10
                         NON-CODING PATTERNS AND LIQUID BIOPSY
     9:00am
                         George Calin, MD Anderson Cancer Center, USA

                         WELCOME AND KEYNOTE
                         Chairs: Amanda Moors, Benjamin Otto
                         Biobanking has evolved as a multidisciplinary field over the past two decades, and ISBER has been at the
                         forefront of all of the significant advances.
                                                  ISBER WELCOME AND OPENING REMARKS
                         9:30am – 9:40am
                                                  Daniel Catchpoole, ISBER President 2020-2021

     9:30am – 10:45am                             ISBER 2021 ANNUAL MEETING BRIEF
                         9:40am – 9:50am
                                                  Amanda Moors, Benjamin Otto, ISBER 2021 Scientific Program Committee Co-Chairs

                                                  ISBER’S TWO DECADES OF CONNECTING AND COLLABORATING THROUGH
                         9:50am – 10:30am         BIOBANKING
                                                  Jim Vaught, Biopreservation & Biobanking, USA

                         10:30am – 10:45am        QUESTION AND ANSWER
     10:45am – 11:15am   Visit with Exhibitors
                         SYMPOSIUM 1A: LESSON TO BE LEARNED FROM THE COVID-19 PANDEMIC
                         Chairs: Amanda Moors, Benjamin Otto, Vanessa Tumilasci
                         Collaboration and sharing of expertise, of samples and of data across academia, industry and governmental
                         institutions is vital for medical research, for successful development of diagnostics tests and treatments, and
                         also for sustainability of research projects. The COVID-19 pandemic, in a microcosmic way, has made the value
                         of successful collaboration between medical centers, academia and the pharmaceutical and biotechnology
                         industries clearly visible. Never before have diagnostic tests and effective vaccines been developed in such a
                         short time. This success story, however, should not end with the recession of the COVID-19 pandemic – rather
                         it should be a rallying cry for more future collaboration. Within this session, we would like to reflect on the year
                         2020, on lessons learned, and obstacles and opportunities to foster closer co-operations across the aisle.
                                                  INTRODUCTION
                         11:15am – 11:25am
                                                  Benjamin Otto, Eppendorf, Germany
                                                  THE PATHWAY OF A SAMPLE FROM ACQUISITION TO VALUE CREATION
                         11:25am – 11:35am
                                                  Vanessa Tumilasci, Trans-Hit Biomarkers, a Brooks Life Sciences Company, Canada
                                                  LESSONS TO LEARN FROM THE CORONA PANDEMIC – INTENSE DATA- AND
                                                  SAMPLE TRANSFER AS KEY SUCCESS FACTOR FOR RAPID DEVELOPMENT OF
                         11:35am – 11:45am
                                                  DIAGNOSTIC TOOLS
     11:15am – 1:45pm                             Andreas Pfützner, Pfützner Science & Health Institute, Germany
     (Concurrent)
                                                  HUMAN ANTIBODIES FOR SARS-COV-2
                         11:45am – 11:55am
                                                  James Crowe, Vanderbilt University Medical Center, USA
                                                  SAMPLE REQUIREMENTS FOR THE DEVELOPMENT AND VALIDATION OF
                                                  NUCLEI ACID DETECTION AND SEROLOGICAL ASSAYS FOR EMERGING
                         11:55am – 12:05pm
                                                  PATHOGENS
                                                  Beatus Ofenloch-Haehnle, Roche Diagnostics, Germany, Chitra Manohar, Roche Diagnostics, USA
                                                  OBTAINING OPTIMAL HUMAN BIOLOGICAL SAMPLES TO SUPPORT CLINICAL
                         12:05pm – 12:15pm        ASSAY DEVELOPMENT AND TESTING
                                                  Nikolaos Gaitatzis, Nexelis GSK, Germany
                         12:15pm – 12:35pm        Networking Break with Exhibits
                                                  SPONSOR SHOWCASE: EXPAND THE FUTURE USE
                                                  OF BIOBANK SAMPLES USING NMR-BASED CLINICAL
                         12:35pm – 12:45pm
                                                  RESEARCH SOLUTIONS
                                                  Claire Cannet, Bruker BioSpin
                         12:45pm – 1:45pm         PANEL DISCUSSION
20
PROGRAM               All times listed in Americas Eastern Daylight Time

 MONDAY, MAY 10
                   SYMPOSIUM 1B: THE MICROBIOME - MAKING A MACRO-IMPACT
                   Chairs: Cari Lichtman, Helen Moore, Cathy Seiler
                   Publications for microbiome research have been increasing exponentially. Research shows microbiota impact
                   human, animal, plant, and environmental health significantly. By integrating sequencing and metabolomics,
                   researchers are looking for relationships between microbiomes, health, and disease. The aim of this session is
                   to showcase the possibilities and limitations associated with microbiome research.
                                              INTRODUCTION
                   11:15am – 11:20am
                                              Cari Lichtman, American Cancer Society, USA
                                              ECOLOGICAL INTERPRETATION OF SKIN MICROBIOME
                   11:20am – 11:45am
                                              Woo Jun Sul, Chung-Ang University, South Korea
                                              MICROBIOMES FROM BIOREPOSITORIES
                   11:45am – 12:10pm
                                              Stephen Greiman, Georgia Southern University, USA
11:15am – 1:45pm   12:10pm – 12:30pm          Networking Break with Exhibits
(Concurrent)
                                              SPONSOR SHOWCASE: EXPAND THE FUTURE USE
                                              OF BIOBANK SAMPLES USING NMR-BASED CLINICAL
                   12:30pm – 12:40pm
                                              RESEARCH SOLUTIONS
                                              Claire Cannet, Bruker BioSpin
                                              COLLECTING AND BANKING BIOSPECIMENS FOR MICROBIOME RESEARCH
                   12:40pm – 1:05pm           IN LARGE COHORT STUDIES
                                              Wei Zheng, Vanderbilt University Medical Center, USA
                                              SARS-COV-2 DETECTION STATUS ASSOCIATES WITH BACTERIAL COMMUNITY
                   1:05pm – 1:30pm            COMPOSITION IN PATIENTS AND THE HOSPITAL ENVIRONMENT
                                              Lisa Marotz, University of California, San Diego, USA
                   1:30pm – 1:45pm            QUESTION AND ANSWER
1:45pm – 2:30pm    Networking Break with Exhibits
                   EDUCATIONAL WORKSHOP 1
                   ASSESSING AND ADDRESSING THE ETHICAL AND GOVERNANCE CHALLENGES OF NETWORKING
2:30pm – 5:00pm    BIOREPOSITORIES
(Concurrent)       Aaron Goldenberg, Case Western Reserve University, USA, Kyle Brothers, University of Louisville, USA, Jean Cadigan, University
                   of North Carolina, USA

                   EDUCATIONAL WORKSHOP 2
2:30pm – 5:00pm    PRACTICAL APPLICATIONS OF DIGITAL PATHOLOGY AND ARTIFICIAL INTELLIGENCE IN BIOBANKING
(Concurrent)       Anil Parwani, The Ohio State University, USA

                   EDUCATIONAL WORKSHOP 3

2:30pm – 5:00pm    KEEPING BIOBANKING SIMPLE: IF KIDS GET IT, SO WILL YOU
                   Mandy Riffel, Children’s Mercy Hospital, USA, Daniel Catchpoole, The Children’s Hospital at Westmead, Australia, Suzanne
(Concurrent)       Vercauteren, BC Children’s Hospital Biobank, Canada

                                                                                                                                                    21
All times listed in Americas Eastern Daylight Time      PROGRAM

      TUESDAY, MAY 11
     8:30am – 5:00pm     Technical Support Open
     8:30am – 5:00pm     Exhibit Hall Open
     8:45am – 9:30am     Coffee and Networking

     9:30am – 9:45am     TOP OF THE MORNING AND AWARD PRESENTATION
                         Chairs: Debra Garcia, Amanda Moors, Benjamin Otto
                         SYMPOSIUM 2A: RESEARCH AND TREATMENT FOR ALL – CONNECTING RESEARCH AND
                         IMPLEMENTATION TO UNDERSERVED AND VULNERABLE COMMUNITIES
                         Chairs: Helen Morrin, Carol Weil
                         Biorepository specimens and data can only fulfill their potential to truly transform health and accelerate
                         scientific discovery if the outcomes are robust and meaningful for all. Biobanks need to be inclusive of all
                         populations, including the underserved and vulnerable communities to address the current lack of diversity
                         and genetic bias, in addition to reducing health disparities. The advent of precision medicine and increased
                         use of genomic tools (including WGS, WES, targeted gene panels, somatic sequencing in cancer, etc.) in
                         both clinical medicine and research has highlighted the urgency to acquire samples from diverse genetic
                         populations and ancestral communities to create meaningful results for all groups. Engagement with these
                         communities face additional challenges, requiring sensitive responses to building trust and partnerships, to
                         meet each community’s needs. This session will include a discussion of the stigma of COVID-19 positivity/
                         disease in these communities.
                                                 INTRODUCTION
                         10:00am – 10:10am       Helen Morrin, University of Otago Christchurch, New Zealand, Carol Weil, National Institute of
                                                 Health, USA
     10:00am – 12:45pm
     (Concurrent)                                HOW TO FAIL AT CONNECTING WITH VULNERABLE AND UNDERSERVED
                         10:10am – 10:35am       POPULATIONS TO IMPLEMENT TREATMENT AND RESEARCH
                                                 Paula Kim, TRAC-Translating Research Across Communities, USA

                                                 NEXUS BETWEEN SCIENCE AND SOCIETY: SOUTHERN AFRICAN EXPERIENCE
                         10:35am – 11:00am
                                                 Himladevi Soodyall, Academy of Science of South Africa (ASSAf), South Africa

                         11:00am – 11:30am       Visit with Exhibitors

                                                 SPONSOR SHOWCASE: INNOVATIONS IN ULTRA-COLD
                         11:35am – 11:45am       STORAGE AND COLD CHAIN TECHNOLOGY
                                                 Joe Laporte, PHC Corporation of North America, USA

                                                 RECRUITING BLACK AND BROWN WOMEN TO THE KOMEN TISSUE BANK: A
                         11:45am – 12:10pm       MOTIVATIONAL ROADMAP
                                                 Kathi Ridley-Merriweather, Susan G. Komen Tissue Bank at the IU Simon Cancer Center, USA

                         12:10pm – 12:45pm       PANEL DISCUSSION
                         SYMPOSIUM 2B: THE NURTURE OF NATURE: ENVIRONMENTAL BIOBANKING FOR A
                         CONNECTED WORLD
                         Chairs: Amanda Moors, Diane McGarvey, Piper Mullins
                         The vastly diverse environmental collections serve as an invaluable resource of knowledge--while this diver-
                         sity is necessary for the understanding of biodiversity, as well as other topics, it also introduces challenges to
                         maintaining a connectedness in a field that has historically been defined by what it is not (i.e., human). Since
                         plants, animals, archaea, and other environmental collections/samples do not possess a human voice, there
     10:00am – 12:45pm   is a risk that they will not be heard. Without the knowledge provided and preserved through environmental
     (Concurrent)        biobanking, though, there is an even greater risk to the prosperity of humanity. This symposium will provide
                         a platform for environmental biobanks to tell their stories about the diverse collections and the value they
                         provide for the biobanking community and beyond.
                                                 INTRODUCTION
                         10:00am – 10:05am       Amanda Moors, National Institute of Standards and Technology, USA, Diane McGarvey, CHTN
                                                 Eastern Division, USA, Piper Mullins, Smithsonian Institution, USA
22
PROGRAM                All times listed in Americas Eastern Daylight Time

 TUESDAY, MAY 11
                                               INTEGRATING THE NORTH PACIFIC THROUGH TWO DECADES OF BANKING
                    10:05am – 10:30am          SEABIRD EGGS
                                               Stacy Schuur, National Institute of Standards and Technology, USA

                                               THE NATURE OF NURTURERS AND NURTURERS IN NATURE; THE STORY OF
                    10:30am – 11:00am          THE COLLABORATIVE BRISTOL BAY BELUGA PROJECT
                                               Eric Gaglione, Georgia Aquarium, USA, Carrie Goertz, Alaska Sea Life Center, USA

                    11:00am – 11:30am          Visit with Exhibitors

10:00am – 12:45pm                              SPONSOR SHOWCASE: INNOVATIONS IN ULTRA-COLD
(Concurrent)        11:30am – 11:40am          STORAGE AND COLD CHAIN TECHNOLOGY
                                               Joe Laporte, PHC Corporation of North America, USA

                                               IMPLEMENTING A QUALITY MANAGEMENT SYSTEM IN CGIAR GENEBANKS:
                                               IMPROVING THE ALIGNMENT OF PEOPLE, POLICY AND TECHNOLOGY IN
                    11:40am – 12:05pm
                                               THE WORLD’S LARGEST AND MOST DIVERSE COLLECTIONS
                                               Janny van Beem, Crop Trust, USA

                                               BRAZILIAN GENETIC RESOURCES BIOBANKS NETWORK
                    12:05pm – 12:30pm
                                               Samuel Paiva, Embrapa Genetic Resources and Biotechnology, Brazil

                    12:30pm – 12:45pm          QUESTION AND ANSWER
12:45pm – 1:30pm    Networking Break with Exhibits
                    CONTRIBUTED PAPER SESSION 1
                    Chair: Marianne Henderson, National Cancer Institute, USA
                    HLA TYPING FROM DRIED BLOOD SPOTS USING LIFECODES SSO TYPING KIT
                    Maemu Gededzha, University of the Witwatersrand Faculty of Health Sciences, South Africa

1:30pm – 2:30pm     BIOBANKING IN THE ERA OF COVID-19: ETHICAL AND GOVERNANCE CHALLENGES
(Concurrent)        Aaron Goldenberg, Case Western Reserve University, USA

                    COVID-19 BIOREPOSITORY – QATAR
                    Eleni Fthenou, Qatar Biobank for Medical Research, Qatar

                    CONTRIBUTED PAPER SESSION 2
                    Chair: Lotte Glück, Glück BioConsult, Switzerland
                    COORDINATING COVID-19 TISSUE PROCUREMENT FROM AUTOPSY: CHALLENGES AND LESSONS
                    LEARNED
                    Aubrey Schild, Duke University, USA

                    ESTABLISHMENT, IMPLEMENTATION AND UTILIZATION OF A HUMAN COVID-19 BIOSPECIMEN
                    BIOREPOSITORY AT UCLA
1:30pm – 2:30pm     Clara Magyar, University of California Los Angeles David Geffen School of Medicine, USA
(Concurrent)
                    A PARADIGM SHIFT - RE-PURPOSING RESOURCES AND INFRASTRUCTURE DURING A PANDEMIC
                    TO ENSURE SUSTAINABILITY
                    Heidi Wagner, University Health Network, Canada

                    QCBIO-AF: QATAR CARDIOVASCULAR BIOREPOSITORY FOR FAMILIAL ATRIAL FIBRILLATION
                    Fatima Mohammed Qafoud, Qatar Foundation Research and Development, Qatar University, Qatar

2:30pm – 3:00pm     Networking Break with Exhibits

                                                                                                                                  23
All times listed in Americas Eastern Daylight Time   PROGRAM

      TUESDAY, MAY 11

                        CORPORATE WORKSHOP 1: TRANSITIONING TO AN AUTOMATED BIOBANK:
                        ADVANTAGES, BEST PRACTICES AND CASE STUDY

                        Michelle Ng Almada, BiOS Product Manager, Hamilton Storage

     3:00pm – 4:00pm    CORPORATE WORKSHOP 2: BIOBANK SAMPLE QUALITY CONTROL WITH
     (Concurrent)       AUTOMATED ELECTROPHORESIS

                        Kyle Luttgeharm, Agilent Technologies, USA, Steffe Sandke, University Hospital Heildelberg, Germany

                        CORPORATE WORKSHOP 3: BREAKTHROUGH LABELING TECHNOLOGIES FOR
                        BIOBANKS AND HIGH-THROUGHPUT LABS

                        Domenic Di Paola, Senior Scientific Sales Manager, GA International, Canada

                        POSTER PRESENTATIONS
     4:00pm – 5:00pm    The poster presenters will be available to discuss their research with delegates via videoconferencing within
                        their poster area. This is an opportunity to ask questions of the presenters and network with fellow delegates.
                        DROP-IN NETWORKING
     7:15pm – 8:00pm    The evening networking activity is an opportunity to connect with delegates from the other side of the globe.
                        Delegates in the Indo-Pacific Rim and China will be just beginning their day.

      WEDNESDAY, MAY 12
     8:30am – 5:00pm    Technical Support Open
     8:30am – 5:00pm    Exhibit Hall Open
                        ROUND TABLE DISCUSSIONS
                        Join us for informal discussions with your fellow delegates.
                        BIOBANKING IN LMICS IN THE POST COVID-19 ERA
                        Facilitator: Zisis Kozlakidis, International Agency for Research on Cancer, France

                        FEDERATED REPRESENTATION OF SPECIMENS COLLECTIONS IN CENTRAL REPOSITORY THROUGH
                        METADATA HARMONIZATION USING ESTABLISHED TERMINOLOGY STANDARDS
                        Facilitator: Michael Keller, Booz Allen Hamilton, USA

                        CHALLENGES AND TIPS FOR WRITING A PLAIN LANGUAGE CONSENT FORM
     8:45am – 9:30am    Facilitator: Helena Ellis, Biobanking Without Borders, LLC, USA
     (Concurrent)
                        IMPACT OF NEW DIAGNOSTIC NMR-TOOLS ONBIOBANK SAMPLE QUALITY AND EFFICIENCY
                        Facilitator: Claire Cannet, Bruker BioSpin GmbH, Germany

                        THE FUTURE ROLE OF BIOBANKING IN THE COMING CELL AND GENE THERAPEUTICS REVOLUTION
                        Facilitator: Scott Masiella, Stirling Ultracold, USA

                        COMPLIANCE EXPERIENCE IN PHARMA USEFUL FOR ACADEMIC BIOBANKS?
                        Facilitator: Erik Steinfelder, Thermo Fisher Scientific, The Netherlands

     9:30am – 9:45am    TOP OF THE MORNING AND AWARD PRESENTATION
                        Chairs: Amanda Moors, Benjamin Otto, Debra Garcia

24
PROGRAM                All times listed in Americas Eastern Daylight Time

 WEDNESDAY, MAY 12
                    SYMPOSIUM 3A: BIOBANKING IN THE FOOD INDUSTRY: WHERE STANDARDS ARE EASY TO
                    DIGEST!
                    Chairs: Daniel Catchpoole, Amanda Moors, Monique Albert
                    Many food industries have systematic stores of biological materials used in food production that have to be
                    maintained through to extremely high standards. Several international organizations or government agen-
                    cies currently cover biobanking for agriculture and food production. There are however gaps between gov-
                    ernments and commercial industry regarding the food production business sector and the role of biobank-
                    ing in these industries needs to be highlighted. This session will explore biobanks in the food industry and
                    their impacts of food standards and quality.
                    You are encouraged to bring the following items when attending this session: 1) a food package with a label
                    on it; 2) bottle of wine and a glass; 3) a jar of olives; 4) an egg; 5) oil; 6) mustard; 7) vinegar; 8) pepper; 9) a
                    small mixing bowl; 10) whisk or fork
                                              INTRODUCTION
                    10:00am – 10:05am         Daniel Catchpoole, Kids Research, The Children’s Hospital at Westmead, Australia
                                              Amanda Moors, National Institute of Standards and Technology, USA
                                              Monique Albert, Ontario Institute for Cancer Research, Canada

                                              LESSONS LEARNED FROM THE NIST FOOD REFERENCE MATERIAL PROGRAM
10:00am – 12:45pm   10:05am – 10:35am
                                              Melissa Meaney Phillips, National Institute of Standards and Technology, USA
(Concurrent)
                                              OLIVE GENETIC RESOURCES CONSERVATION AND CATALOGUING IN THE
                    10:35am – 11:05am         GERMPLASM BANK IOC NETWORK: GEN4OLIVE AND THOC PROJECTS
                                              Concepcion Muñoz Díez, University of Cordoba, Spain

                    11:05am – 11:35am         Visit with Exhibitors

                                              SPONSOR SHOWCASE: THE HUNT STUDY
                    11:35am – 11:45am
                                              Anne Jorunn Vikdal, HUNT biobank, Norway

                                              FERMENTATION MICROBES-THE REAL WORKERS IN INNOVATIVE PRODUCTS
                    11:45am – 12:15pm         FOR THE FUTURE
                                              Simon Dillon, Australian Wine Research Institute, Australia

                                              STANDARDS AND QUALITY IN YOUR KITCHEN
                    12:15pm – 12:25pm
                                              Jeanette Simeon-Dubach, Directnetwork GmbH, Switzerland

                    12:25pm – 12:45pm         QUESTION AND ANSWER
                    SYMPOSIUM 3B: BIOBANK SUSTAINABILITY IN LIGHT OF THE COVID-19 PANDEMIC
                    Chairs: Kirstin Goldring, Marianne Henderson, Daniel Simeon-Dubach
                    Sustainable behavior is a central focus for all research and clinical activities, including biobanking. The expe-
                    rience with the COVID-19 pandemic brought new challenges in all aspects of our lives, let alone our work.
                    It also has brought challenges as well as opportunities to sustained research biobanking and clinical care/
                    biobanking. This symposium will highlight biobanking from several perspectives, including biobanking to
                    serve the clinic and creation of the vaccines, as well as research biobanking. The speakers will share their
                    perspectives and lessons-learned from before, during and emerging from the pandemic, on the value and
10:00am – 12:45pm   practicality of sustained biobanking. A panel discussion with audience participation will follow the talks.
(Concurrent)
                                              INTRODUCTION
                    10:00am – 10:10am
                                              Marianne Henderson, National Cancer Institute, USA

                                              WHAT DID COVID TELL US ABOUT THE VALUE OF BIOBANKS?
                    10:10am – 10:30am
                                              Phil Quinlan, University of Nottingham, UK

                                              SUSTAINABLE COVID-19 SAMPLE COLLECTION IN CHALLENGING TIMES
                    10:30am – 10:50am
                                              Amir Gander, University College London, UK

                                                                                                                                           25
You can also read